Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-24-003588
Accepted
2024-11-27 00:15:17
Documents
1
Effectiveness Date
2024-11-26
Registration Form
S-1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-24-003588.txt   2048
Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-283212 | Film No.: 241506123
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)